Alivus Life Sciences Ltd.

The revenue for the December 2024 quarter is pegged at Rs. 6418.44 millions, about 12.05% up against Rs. 5728.04 millions recorded during the year-ago period.Profit saw a slight increase of 15.32%to Rs. 1369.60  millions from Rs. 1187.65 millions.The company reported a good operating profit of 2007.64 millions compared to 1742.47 millions of corresponding previous quarter.

(Rs. in Million)

	Quarter ended			Year to Date			Year ended
	202412	202312	% Var	202412	202312	% Var	202403	202303	% Var
Sales	6418.44	5728.04	12.05	17373.39	17466.17	-0.53	22832.14	21612.20	5.64
Other Income	104.56	16.91	518.33	244.82	89.11	174.74	120.42	289.57	-58.41
PBIDT	2007.64	1742.47	15.22	5086.34	5417.12	-6.11	6862.88	6712.50	2.24
Interest	4.58	3.87	18.35	11.54	11.82	-2.37	15.46	5.47	182.63
PBDT	2003.06	1738.60	15.21	5074.80	5405.30	-6.11	6847.42	6707.03	2.09
Depreciation	151.59	131.77	15.04	446.39	389.18	14.70	534.52	420.94	26.98
PBT	1851.47	1606.83	15.23	4628.41	5016.12	-7.73	6312.90	6286.09	0.43
TAX	481.87	419.18	14.96	1190.82	1286.60	-7.44	1604.02	1616.48	-0.77
Deferred Tax	13.81	30.57	-54.82	45.19	75.00	-39.75	81.88	110.37	-25.81
PAT	1369.60	1187.65	15.32	3437.59	3729.52	-7.83	4708.88	4669.61	0.84
Equity	245.07	245.05	0.01	245.07	245.05	0.01	245.05	245.05	0.00
PBIDTM(%)	31.28	30.42	2.82	29.28	31.01	-5.60	30.06	31.06	-3.22